Literature DB >> 28477634

Pulmonary Toxicities from Conventional Chemotherapy.

Paul Leger1, Andrew H Limper2, Fabien Maldonado3.   

Abstract

Despite significant recent progress in precision medicine and immunotherapy, conventional chemotherapy remains the cornerstone of the treatment of most cancers. Chemotherapy-induced lung toxicity represents a serious diagnostic challenge for health care providers and requires careful consideration because it is a diagnosis of exclusion with significant impact on therapeutic decisions. This review aims to provide clinicians with a valuable guide in assessing their patients with possible chemotherapy-induced lung toxicity.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bronchoscopy; Chemotherapy; Interstitial lung disease; Lung toxicity; Radiation therapy

Mesh：

Year:  2017        PMID： 28477634     DOI： 10.1016/j.ccm.2017.01.002

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN： 0272-5231            Impact factor:   2.878


  7 in total

Review 1.  Anaesthesia after neoadjuvant chemotherapy, immunotherapy or radiotherapy.

Authors:  M D Groenewold; C G Olthof; D J Bosch
Journal:  BJA Educ       Date:  2021-10-16

Review 2.  Busulfan-Induced Lung Injury in Pediatric Oncology Patients-Review of the Literature with an Illustrative Case.

Authors:  Nusa Matijasic; Aleksandra Bonevski; Visnja Tokic Pivac; Ivan Pavic
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2019-09-17       Impact factor: 1.349

3.  Modulation of COX-2 and NADPH oxidase-4 by alpha-lipoic acid ameliorates busulfan-induced pulmonary injury in rats.

Authors:  Mona G Elhadidy; Ahlam Elmasry; Hassan Reda Hassan Elsayed; Mohammad El-Nablaway; Shereen Hamed; Mahmoud M Elalfy; Mohammed R Rabei
Journal:  Heliyon       Date:  2021-10-13

Review 4.  Incidence and prognostic factors in severe drug-induced interstitial lung disease caused by antineoplastic drug therapy in the real world.

Authors:  Sawako Kaku; Hidehito Horinouchi; Hirokazu Watanabe; Kan Yonemori; Takuji Okusaka; Narikazu Boku; Naoya Yamazaki; Akira Kawai; Yuichiro Ohe; Masahiko Kusumoto
Journal:  J Cancer Res Clin Oncol       Date:  2022-02-07       Impact factor: 4.322

5.  CDK 4/6 inhibitor induced lung injury: a case report and review of literature.

Authors:  Namrata Mathew; Anjana Joel; Anand George Andrews; Ajoy Oommen John; Ashish Singh
Journal:  Ecancermedicalscience       Date:  2021-06-07

6.  Osteogenic Sarcoma in an Adolescent With Cystic Fibrosis: Successful Treatment Despite Significant Obstacles.

Authors:  Thomas J C Ruffles; Ryan Black; Wayne Nicholls; Barbara Laing; Alan Isles
Journal:  Front Pediatr       Date:  2018-09-21       Impact factor: 3.418

7.  A polyoxyethylene sorbitan oleate modified hollow gold nanoparticle system to escape macrophage phagocytosis designed for triple combination lung cancer therapy via LDL-R mediated endocytosis.

Authors:  Yan Shen; Yun Xia; Ershuang Yang; Zixuan Ye; Yuan Ding; Jiasheng Tu; Yong Zhang; Pengcheng Xu
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.